Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | TDP2 | O95551 | 3/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2379906 | 0.93 | ALDH1A1 (0.37) | MAPK1ALDH1A1PDK2PTGS2TDP2 | |
| SCHEMBL2380269 | 0.91 | PDK2 (0.36) | MAPK1ALDH1A1PDK2PTGS2KDM4E | |
| SCHEMBL13855113 | 0.88 | PTGS2 (0.35) | MAPK1ALDH1A1PDK2PTGS2PGR | |
| SCHEMBL15763802 | 0.88 | ALDH1A1 (0.37) | MAPK1ALDH1A1PDK2PGRTDP2 | |
| SCHEMBL13819625 | 0.86 | DPP4 (0.36) | ALDH1A1PDK2PTGS2KDM4EMAPT | |
| SCHEMBL12560713 | 0.86 | PDK2 (0.39) | MAPK1ALDH1A1PDK2NPC1RAB9A | |
| SCHEMBL12560750 | 0.86 | PTGS2 (0.37) | MAPK1ALDH1A1PDK2PTGS2PGR | |
| SCHEMBL16621993 | 0.86 | MEN1 (0.40) | ALDH1A1PDK2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2379782 | 0.86 | ALDH1A1 (0.35) | MAPK1ALDH1A1PDK2PTGS2 | |
| SCHEMBL13819559 | 0.86 | MEN1 (0.40) | ALDH1A1PDK2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143781-B2 | Organic electroluminescent compounds with high efficiency and display device using the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2012-03-27 | — | — | US | disclosed |
| US-8143781-B2 | Organic electroluminescent compounds with high efficiency and display device using the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2012-03-27 | — | — | US | disclosed |
| US-20110109223-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-05-12 | — | — | US | disclosed |
| US-20110109223-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110109223-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | EED, EPHA4, NECTIN4 | MAPK1 2989/4885ALDH1A1 216/4885PDK2 2271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.